Clinical characteristics and booster vaccine effectiveness of the Omicron variant
Lijun Sun, Biye Zhou, Yijia Guo, Yunfei Huang, Zihui Tang, Zhaojun Wu, Yuwei Li, Liping Zhao, Yi Shan, Xiaolong Xu, Hui Jiang · 2024
Read Clinical characteristics and booster vaccine effectiveness of the Omicron variant by Lijun Sun, Biye Zhou, Yijia Guo, Yunfei Huang, Zihui Tang, Zhaojun Wu, Yuwei Li, Liping Zhao, Yi Shan, Xiaolong Xu, Hui Jiang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11600739.txt.
Description
Lijun Sun and co-authors describe Beijing's first big Omicron wave and test how much booster shots helped. The wave hit soon after China eased its three-year COVID-19 restrictions in late 2022. Their 2024 paper gathers hospital records for 1,495 patients from December 2022 into January 2023, along with each patient's vaccine history.
Just over half the patients were men. The team compared people by vaccine course: boosted, fully dosed, or partly dosed. They charted symptoms, severity, and the timing of illness, diagnosis, and admission. Survival methods then weighed the risk of death, breathing machines, and intensive care across the groups. The study gives one of the fullest pictures of that sudden wave, and it measures the booster's added protection in a population meeting Omicron largely for the first time.
Catalog record
| CREATOR | Lijun Sun, Biye Zhou, Yijia Guo, Yunfei Huang, Zihui Tang, Zhaojun Wu, Yuwei Li, Liping Zhao, Yi Shan, Xiaolong Xu, Hui Jiang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |